AAAAAA

   
Results: 1-20 |
Results: 20
Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate
Authors: Behe, M Du, J Becker, W Behr, T Angerstein, C Marquez, M Hiltunen, J Nilsson, S Holmberg, AR
Citation: M. Behe et al., Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate, MED ONCOL, 18(1), 2001, pp. 59-64
Imaging tumors with peptide-based radioligands
Authors: Behr, TM Gotthardt, M Barth, A Behe, M
Citation: Tm. Behr et al., Imaging tumors with peptide-based radioligands, Q J NUCL M, 45(2), 2001, pp. 189-200
Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?
Authors: Behr, TM Behe, M Jungclas, H Jungclas, H Becker, W Sgouros, G
Citation: Tm. Behr et al., Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?, EUR J NUCL, 28(9), 2001, pp. 1435-1436
Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model
Authors: Gratz, S Behe, M Boerman, OC Kunze, E Schulz, H Eiffert, H O'Reilly, T Behr, TM Angerstein, C Nebendahl, K Kauer, F Becker, W
Citation: S. Gratz et al., Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model, NUCL MED C, 22(9), 2001, pp. 1003-1013
Trastuzumab and breast cancer.
Authors: Behr, TM Behe, M Wormann, B
Citation: Tm. Behr et al., Trastuzumab and breast cancer., N ENG J MED, 345(13), 2001, pp. 995-996
Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate
Authors: Meller, J Wisheu, S Munzel, U Behe, M Gratz, S Becker, W
Citation: J. Meller et al., Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate, EUR J NUCL, 27(9), 2000, pp. 1286-1291
Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies
Authors: Behr, TM Behe, M Lohr, M Sgouros, G Angerstein, C Wehrmann, E Nebendahl, K Becker, W
Citation: Tm. Behr et al., Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies, EUR J NUCL, 27(7), 2000, pp. 753-765
Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide
Authors: Bangard, M Behe, M Guhlke, S Otte, R Bender, H Maecke, HR Biersack, HJ
Citation: M. Bangard et al., Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide, EUR J NUCL, 27(6), 2000, pp. 628-637
Fever of unknown origin: prospective comparison of [F-18]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET
Authors: Meller, J Altenvoerde, G Munzel, U Jauho, A Behe, M Gratz, S Luig, H Becker, W
Citation: J. Meller et al., Fever of unknown origin: prospective comparison of [F-18]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET, EUR J NUCL, 27(11), 2000, pp. 1617-1625
(TC)-T-99m-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis
Authors: Gratz, S Raddatz, D Hagenah, G Behr, T Behe, M Becker, W
Citation: S. Gratz et al., (TC)-T-99m-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis, INT J CARD, 75(1), 2000, pp. 75-84
Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy
Authors: Froidevaux, S Heppeler, A Eberle, AN Meier, AM Hausler, M Beglinger, C Behe, M Powell, P Macke, HR
Citation: S. Froidevaux et al., Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy, ENDOCRINOL, 141(9), 2000, pp. 3304-3312
Diagnostic applications of radiolabeled peptides in nuclear endocrinology
Authors: Behr, TM Behe, M Becker, W
Citation: Tm. Behr et al., Diagnostic applications of radiolabeled peptides in nuclear endocrinology, Q J NUCL M, 43(3), 1999, pp. 268-280
Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
Authors: Behr, TM Sgouros, G Stabin, MG Behe, M Angerstein, C Blumenthal, RD Apostolidis, C Molinet, R Sharkey, RM Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S
Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential
Authors: Behr, TM Behe, M Angerstein, C Gratz, S Mach, R Hagemann, L Jenner, N Stiehler, M Frank-Raue, K Raue, F Becker, W
Citation: Tm. Behr et al., Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential, CLIN CANC R, 5(10), 1999, pp. 3124S-3138S
Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
Authors: Behr, TM Salib, AL Liersch, T Behe, M Angerstein, C Blumenthal, RD Fayyazi, A Sharkey, RM Ringe, B Becker, H Wormann, B Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study, CLIN CANC R, 5(10), 1999, pp. 3232S-3242S
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
Authors: Behr, TM Wormann, B Gramatzki, M Riggert, J Gratz, S Behe, M Griesinger, F Sharkey, RM Kolb, HJ Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies, CLIN CANC R, 5(10), 1999, pp. 3304S-3314S
Radiometal-labelled macrocyclic chelator-derivatised somatostatin analoguewith superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy
Authors: Heppeler, A Froidevaux, S Macke, HR Jermann, E Behe, M Powell, P Hennig, M
Citation: A. Heppeler et al., Radiometal-labelled macrocyclic chelator-derivatised somatostatin analoguewith superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy, CHEM-EUR J, 5(7), 1999, pp. 1974-1981
Yttrium-90 DOTATOC: first clinical results
Authors: Otte, A Herrmann, R Heppeler, A Behe, M Jermann, E Powell, P Maecke, HR Muller, J
Citation: A. Otte et al., Yttrium-90 DOTATOC: first clinical results, EUR J NUCL, 26(11), 1999, pp. 1439-1447
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
Authors: Behr, TM Jenner, N Behe, M Angerstein, C Gratz, S Raue, F Becker, W
Citation: Tm. Behr et al., Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors, J NUCL MED, 40(6), 1999, pp. 1029-1044
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model
Authors: Behr, TM Behe, M Stabin, MG Wehrmann, E Apostolidis, C Molinet, R Strutz, F Fayyazi, A Wieland, E Gratz, S Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model, CANCER RES, 59(11), 1999, pp. 2635-2643
Risultati: 1-20 |